Thomas Karagiannis (T Karagiannis)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Venues

Diabetes, obesity & metabolism

Diabetologia

Diabetes care

Annals of internal medicine

Aristotle University of Thessaloniki

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aristotle University of Thessaloniki Jan 01 2009

Greece

Research Associate :: Second Medical Department

Publications

Thomas Karagiannis, Apostolos Tsapas, Apostolos Tsapas, Konstantinos A Toulis, Michael A Nauck
A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes. Diabetes care 47 (2) (2024)
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia 67 (7) (2024)
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia 67 (7) (2024)
Thomas Karagiannis, Apostolos Tsapas, Apostolos Tsapas, Konstantinos A Toulis, Michael A Nauck
A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes. Diabetes care 47 (2) (2024)
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia (2024)
Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Athina Stamati, Panagiota Kakotrichi, Aris Liakos, Despoina Vasilakou, Nikolaos Kakaletsis, Apostolos Tsapas, Apostolos Tsapas
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials. Diabetologia 67 (7) (2024)
Thomas Karagiannis, Apostolos Tsapas, Apostolos Tsapas, Konstantinos A Toulis, Michael A Nauck
A Methodological Framework for Meta-analysis and Clinical Interpretation of Subgroup Data: The Case of Major Adverse Cardiovascular Events With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes. Diabetes care 47 (2) (2024)
Georgios Kostopoulos, Ioannis Doundoulakis, Konstantinos A Toulis, Thomas Karagiannis, Apostolos Tsapas, Anna-Bettina Haidich
Prognostic models for heart failure in patients with type 2 diabetes: a systematic review and meta-analysis. Heart (British Cardiac Society) (2023)
Thomas Karagiannis, Apostolos Tsapas, Apostolos Tsapas
Socioeconomic aspects of incretin-based therapy. Diabetologia (2023)
Ioannis Avgerinos, Thomas Karagiannis, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Effects of sodium-glucose co-transporter-2 inhibitors by background cardiovascular medications: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2023)
Aris Liakos, Thomas Karagiannis, Ioannis Avgerinos, Apostolos Tsapas, Apostolos Tsapas
Burden and Coping Strategies of Hypoglycemia in People with Diabetes. Current diabetes reviews (2023)
Athina Stamati, Georgia Sotiriou, Thomas Karagiannis, Athanasios Christoforidis
Efficacy and safety of carbohydrate restriction in patients with type 1 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism (2023)
Ioannis Avgerinos, Thomas Karagiannis, Aris Liakos, Apostolos Tsapas, Apostolos Tsapas
Racial, ethnic and sex disparities among participants in cardiovascular outcomes trials in type 2 diabetes: A systematic review and descriptive analysis. Diabetes, obesity & metabolism (2022)
Thomas Karagiannis, Ioannis Avgerinos, Aris Liakos, Stephano Del Prato, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis. Diabetologia 65 (8) (2022)
Ioannis Avgerinos, Apostolos Manolopoulos, Theodoros Michailidis, Konstantinos Kitsios, Aris Liakos, Thomas Karagiannis, Konstantinos Dimitrakopoulos, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis. Diabetes, obesity & metabolism 23 (3) (2021)
Ioannis Avgerinos, Georgia Papanastasiou, Thomas Karagiannis, Theodoros Michailidis, Aris Liakos, Maria Mainou, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 23 (10) (2021)
Ioannis Avgerinos, Thomas Karagiannis, Panagiota Kakotrichi, Theodoros Michailidis, Aris Liakos, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Sotagliflozin for patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 24 (1) (2021)
Apostolos Tsapas, Thomas Karagiannis, Panagiota Kakotrichi, Ioannis Avgerinos, Chrysanthi Mantsiou, Georgios Tousinas, Apostolos Manolopoulos, Aris Liakos, Konstantinos Malandris, David R Matthews, Apostolos Tsapas
Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis. Diabetes, obesity & metabolism 23 (9) (2021)
Apostolos Tsapas, Thomas Karagiannis, Ioannis Avgerinos, David R Matthews
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes. Annals of internal medicine 174 (1) (2021)
Chrysanthi Mantsiou, Thomas Karagiannis, Panagiota Kakotrichi, Konstantinos Malandris, Ioannis Avgerinos, Aris Liakos, Apostolos Tsapas, Apostolos Tsapas
Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 22 (10) (2020)
Apostolos Tsapas, Ioannis Avgerinos, Thomas Karagiannis, Konstantinos Malandris, Apostolos Manolopoulos, Panagiotis Andreadis, Aris Liakos, David R Matthews, Eleni Bekiari
Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes: A Systematic Review and Network Meta-analysis. Annals of internal medicine 173 (4) (2020)
Thomas Karagiannis, Ioannis Avgerinos, Maria Toumpalidou, Aris Liakos, Konstantinos Kitsios, Georgios Dimitriadis, Nikolaos Papanas, Alexandra Bargiota, Iakovos Avramidis, Anastasia Katsoula, Anastasios Tentolouris, Thekla Chatziadamidou, Stathis Giannakopoulos, Stavros Alexiadis, Kalliopi Kotsa, Apostolos Tsapas, Eleni Bekiari
Patients' and Clinicians' Preferences on Outcomes and Medication Attributes for Type 2 Diabetes: a Mixed-Methods Study. Journal of general internal medicine (2020)
Thomas Karagiannis, P Andreadis, A Manolopoulos, K Malandris, I Avgerinos, A Karagianni, A Tsapas
Decision aids for people with Type 2 diabetes mellitus: an effectiveness rapid review and meta-analysis. Diabetic medicine : a journal of the British Diabetic Association 36 (5) (2019)
Ioannis Avgerinos, Theodoros Michailidis, Aris Liakos, Thomas Karagiannis, David R Matthews, Apostolos Tsapas, Apostolos Tsapas
Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 22 (3) (2019)
Panagiotis Andreadis, Thomas Karagiannis, Konstantinos Malandris, Ioannis Avgerinos, Aris Liakos, Apostolos Manolopoulos, Apostolos Tsapas, David R Matthews, Apostolos Tsapas
Semaglutide for type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes, obesity & metabolism 20 (9) (2018)
Ioannis Avgerinos, Thomas Karagiannis, Konstantinos Malandris, Aris Liakos, Maria Mainou, Apostolos Tsapas, David R Matthews, Apostolos Tsapas
Glucagon-like peptide-1 receptor agonists and microvascular outcomes in type 2 diabetes: A systematic review and meta-analysis. Diabetes, obesity & metabolism 21 (1) (2018)

Thomas Karagiannis.css-eqlu8i{font-size:small;padding-left:4px;} (T Karagiannis)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Karagiannis (T Karagiannis)